Comparison of Resting Heart and Respiratory Rate Measurements Acquired by Contactless Radar Sensors, Electrocardiography, and Capnography (Vitalpercept)
Determine agreement (accuracy) of resting heart rate measured by Vitalpercept when compared to an FDA-cleared electrocardiograph (ECG) device, LifeSignals Wireless Biosensor.
Determine agreement (accuracy) of resting respiratory rate measured by Vitalpercept when compared to an FDA-cleared capnographer, Capnostream 20.
Enrollment
100 estimated patients
Sex
All
Ages
21+ years old
Volunteers
Accepts Healthy Volunteers
Inclusion criteria
Male or female subjects ≥ 21 years of age at the time of signing the informed consent.
Subjects willing to sign the informed consent and capable of committing to the duration of the study.
Subjects with the ability to lie flat, lie on left side, lie on right side, and sit in a chair.
Subjects who are able to breathe through their nose for the capnography assessment.
Subjects that have a diagnosis of a cardiac, pulmonary, or cardio-pulmonary condition (e.g., Congestive Heart Failure, COPD, Asthma) will be assigned to Group 1.
Subjects who are not known to have a cardiac, pulmonary, or cardio-pulmonary condition will be assigned to Group 2.
Exclusion criteria
Subjects who are prone to excessive coughing and excessive movement
Subjects who have a condition that involves uncontrollable movement of the body such as Parkinson's Disease or Essential Tremor.
Subjects with a history of allergy to adhesive, latex or Nuprep.
Trial design
100 participants in 2 patient groups
Group 1
Description:
Subjects that have a diagnosis of a cardiac, pulmonary, or cardio-pulmonary condition (e.g., Congestive Heart Failure, COPD, Asthma) will be assigned to Group 1.
Treatment:
Diagnostic Test: Vitalpercept
Group 2
Description:
Subjects who are not known to have a cardiac, pulmonary, or cardio-pulmonary condition will be assigned to Group 2.